HOME >> BIOLOGY >> NEWS
Classical subject underpins new biomedical advances

The ancient art of physiology -- the study of how the body works and how to repair it when things go wrong--has seen an upsurge in importance as it now plays a key role in the understanding of how genes work to support the human body.

At his inaugural lecture on Thursday (17 March), University of Edinburgh Professor Michael J. Shipston will say that our ability to isolate, manipulate and visualise gene products in cells and whole animals has revolutionized the understanding of the body and its functions. This in turn has caused a rise in demand for scientists with physiological training, to fully exploit these advances.

He will say: "This classical subject was described by Aristotle as the study of the whole organism and its component parts. It is now at the forefront of current biomedical advances as it seeks to understand how the catalogue of our genes, the human genome, is exploited to generate and maintain the human body."

Michael J. Shipston, Professor of Physiology and Director of the Centre for Integrative Physiology at the University, will discuss the importance of communication within and between cells of the body, in order to keep its 30kg of cells warm, fed and able to reproduce in 20 litres of water. To achieve this, cells need to overcome a major paradox -- the transfer of information, nutrients and waste products across fatty cell membranes which are designed to limit the transfer of these important molecules in order to keep the cell's environment separate from that of its neighbours.

He will say that art influences his approach to science, as by visualising the body's life processes, such as cells releasing hormones or single molecules in motion, he is able to obtain new insights into the basic processes which make the body work.

Physiology and the Art of Communication by Professor Michael Shipston, College of Medicine and Veterinary Medicine, University of Edinburgh: Thursday, 17 March 2005 in the Anatomy Lec
'"/>

Contact: Linda Menzies
linda.menzies@ed.ac.uk
44-131-650-6382
University of Edinburgh
16-Mar-2005


Page: 1 2

Related biology news :

1. Pavlovs cockroach: Classical conditioning of salivation in an insect
2. A prickly subject: The sea urchin genome is sequenced
3. Fruit flies aboard space shuttle subjects of UCF, UC Davis study on immunity and space
4. Student work in human subjects protection sought for FDA conference at UH
5. New proteomics research promises to revolutionize biomedical discovery
6. Bee researcher at Arizona State University is 1 of 20 new Pew Scholars in the biomedical sciences
7. Methodist, University of Houston, Cornell combine biomedical imaging expertise
8. Research center unites biomedical competitors to fund medical technology development
9. UT Metroplex institutions to collaborate on biomedical research
10. APS President-Elect Carey urges 6.7 percent increase for biomedical research
11. Polymers show promise for gene delivery, tissue scaffolds, other biomedical applications

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Classical subject underpins new biomedical advances

(Date:7/23/2014)... Ind. Spinach gave Popeye super strength, but it ... a group of scientists: the ability to convert sunlight ... physicists are part of an international group using spinach ... by which plants convert the sun,s energy into carbohydrates ... study are part of the most efficient system ever ...
(Date:7/23/2014)... , , , ... , , , , ... lifespan. The idea, they argue, would be to target the... , , ... , , , , ... , , , , , , , Medicine focuses almost entirely on ...
(Date:7/23/2014)... its grip is affecting more than the color of people,s ... a heat-loving amoeba commonly found in warm freshwater bodies, such ... made warmer than usual this year. , A 9-year-old Kansas ... after swimming in several area lakes. The amoeba enters the ... the brain. Nose plugs can lower the odds of this ...
Breaking Biology News(10 mins):Spinach could lead to alternative energy more powerful than Popeye 2Strategy proposed for preventing diseases of aging 2Strategy proposed for preventing diseases of aging 3Strategy proposed for preventing diseases of aging 4Strategy proposed for preventing diseases of aging 5Diseases of another kind 2
(Date:7/23/2014)... , July 23, 2014  Having the right people ... vital to accelerating business growth and achieving clinical and ... Association (AHA) Leadership Summit, July 20-22, 2014, in ... of hospital executives and healthcare experts discussing how partnerships ... Carrocino , President & Chief Executive Officer of Cape ...
(Date:7/23/2014)... StemGenex® , the leading resource for ... at improving the lives of patients dealing with degenerative ... disease. StemGenex believes that a commitment to the ... when providing care to patients with degenerative diseases. ... accessible to the millions of individuals currently living with ...
(Date:7/23/2014)... Iowa (PRWEB) July 23, 2014 DuPont ... the business as vice president of Agricultural Biotechnology (ABT), ... Biotechnology where he served most recently as president, chief ... biotechnology and business leadership in the seed and crop ... said Paul E. Schickler , president of DuPont ...
(Date:7/23/2014)... -- regulated information -- UCB today announced an important ... positive topline results from the latest Phase 3 ... to evaluate the efficacy and safety of ... compared to placebo, as adjunctive treatment in adult ... controlled despite treatment with one or two concomitant ...
Breaking Biology Technology:MSC and Cape Regional Medical Center Partner to Improve Cost, Quality and Outcomes 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 2StemGenex® Gives Hope to Parkinson’s Patients through New Stem Cell Clinical Study 3DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 2DuPont Pioneer Names Neal Gutterson to Lead Agricultural Biotechnology 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7
Cached News: